Last 48 quarters of trend data · Healthcare · Medical - Instruments & Supplies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 50.61 | 42.31 | 50.55 | 64.07 | 57.34 | 75.06 | 64.49 | 69.41 | 78.73 | 76.17 | 66.07 | 49.91 | 62.99 | 72.44 | 63.87 | 72.90 | 52.07 | 59.03 | 75.42 | 86.37 | 79.66 |
| — | -43.6% | -21.6% | -7.7% | -27.2% | -1.5% | -2.4% | +39.1% | +25.0% | +5.1% | +3.5% | -31.5% | +21.0% | +22.7% | -15.3% | -15.6% | -34.6% | +9.4% | +43.3% | +28.0% | +17.2% | |
| P/S Ratio | 13.98 | 12.32 | 14.97 | 17.80 | 16.15 | 20.27 | 20.03 | 19.67 | 21.86 | 19.97 | 19.02 | 15.67 | 15.01 | 17.39 | 13.40 | 14.31 | 10.85 | 12.00 | 18.59 | 21.28 | 21.65 |
| — | -39.2% | -25.3% | -9.5% | -26.1% | +1.5% | +5.3% | +25.6% | +45.6% | +14.8% | +41.9% | +9.5% | +38.4% | +45.0% | -27.9% | -32.8% | -49.9% | -37.2% | +7.5% | +14.2% | +9.1% | |
| P/B Ratio | 8.05 | 7.79 | 9.43 | 11.38 | 9.49 | 11.02 | 10.49 | 11.49 | 11.37 | 10.85 | 10.24 | 9.02 | 8.29 | 10.22 | 8.05 | 8.52 | 5.84 | 6.02 | 9.06 | 11.00 | 10.56 |
| — | -29.3% | -10.2% | -1.0% | -16.5% | +1.5% | +2.5% | +27.4% | +37.0% | +6.2% | +27.2% | +5.8% | +42.1% | +69.8% | -11.1% | -22.5% | -44.7% | -41.3% | +3.7% | +8.7% | +15.0% | |
| P/FCF | 56.49 | 37.58 | 51.28 | 69.90 | 54.99 | 88.31 | 97.08 | 93.00 | 97.13 | 129.05 | 1530.55 | — | 89.61 | 62.67 | 128.24 | 78.89 | 78.90 | 57.75 | 216.24 | 79.18 | 70.16 |
| — | -57.4% | -47.2% | -24.8% | -43.4% | -31.6% | -93.7% | — | +8.4% | +105.9% | +1093.5% | — | +13.6% | +8.5% | -40.7% | -0.4% | +12.5% | -3.5% | +305.5% | +80.8% | -31.1% | |
| EV / EBITDA | 38.00 | 29.83 | 38.81 | 46.32 | 43.22 | 54.09 | 61.89 | 54.69 | 63.36 | 58.00 | 60.93 | 51.49 | 44.00 | 52.96 | 46.22 | 48.65 | 33.78 | 36.96 | 55.66 | 61.55 | 57.27 |
| — | -44.9% | -37.3% | -15.3% | -31.8% | -6.7% | +1.6% | +6.2% | +44.0% | +9.5% | +31.8% | +5.8% | +30.3% | +43.3% | -17.0% | -21.0% | -41.0% | -21.3% | +23.6% | +25.2% | -7.6% | |
| EV / EBIT | 46.73 | 35.87 | 43.55 | 52.60 | 46.48 | 58.42 | 66.57 | 58.06 | 65.49 | 60.18 | 65.47 | 57.23 | 48.42 | 59.47 | 52.63 | 59.00 | 40.98 | 43.93 | 68.04 | 72.00 | 65.17 |
| — | -38.6% | -34.6% | -9.4% | -29.0% | -2.9% | +1.7% | +1.5% | +35.3% | +1.2% | +24.4% | -3.0% | +18.1% | +35.4% | -22.6% | -18.1% | -37.1% | -16.1% | +29.0% | +22.9% | -16.3% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.0% | 67.8% | 66.1% | 66.4% | 66.4% | 66.3% | 64.7% | 68.0% | 67.4% | 68.3% | 65.9% | 66.2% | 66.9% | 66.7% | 65.6% | 67.1% | 67.6% | 67.2% | 67.9% | 68.4% | 69.2% |
| — | +2.2% | +2.1% | -2.4% | -1.6% | -2.9% | -1.8% | +2.7% | +0.7% | +2.3% | +0.4% | -1.3% | -0.9% | -0.7% | -3.3% | -1.9% | -2.4% | -3.9% | -2.8% | +1.5% | +3.0% | |
| Operating Margin | 29.3% | 33.6% | 30.9% | 30.2% | 30.3% | 30.5% | 25.7% | 30.4% | 28.3% | 28.2% | 24.8% | 23.3% | 26.7% | 26.4% | 22.9% | 22.5% | 25.6% | 26.1% | 27.4% | 29.0% | 31.5% |
| — | +10.3% | +20.3% | -1.0% | +7.1% | +7.9% | +3.3% | +30.4% | +6.0% | +7.0% | +8.7% | +3.7% | +4.3% | +1.0% | -16.7% | -22.5% | -18.8% | -25.2% | -15.0% | -7.2% | +25.7% | |
| Net Margin | 28.4% | 28.3% | 29.6% | 27.7% | 28.1% | 27.0% | 31.0% | 28.4% | 27.7% | 26.2% | 28.8% | 31.4% | 23.8% | 24.0% | 20.9% | 19.6% | 20.8% | 20.2% | 24.6% | 24.5% | 27.1% |
| — | +4.8% | -4.3% | -2.4% | +1.4% | +2.9% | +7.5% | -9.6% | +16.3% | +9.4% | +37.6% | +60.1% | +14.6% | +18.5% | -14.8% | -20.0% | -23.3% | -42.8% | -25.5% | -10.7% | -6.9% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 16.6% | 4.6% | 4.6% | 4.5% | 4.0% | 3.7% | 4.1% | 4.3% | 3.7% | 3.7% | 4.0% | 4.7% | 3.4% | 3.6% | 3.2% | 2.9% | 2.7% | 2.5% | 3.0% | 3.2% | 3.4% |
| — | +21.7% | +11.7% | +6.7% | +8.5% | +2.5% | +4.3% | -8.6% | +9.7% | +1.0% | +25.2% | +62.7% | +23.8% | +43.2% | +5.0% | -11.5% | -19.5% | -48.3% | -29.1% | -15.3% | -2.1% | |
| ROA | 14.5% | 4.0% | 4.0% | 4.0% | 3.6% | 3.3% | 3.7% | 3.7% | 3.3% | 3.2% | 3.5% | 4.0% | 2.9% | 3.1% | 2.7% | 2.5% | 2.4% | 2.2% | 2.7% | 2.9% | 3.0% |
| — | +19.4% | +9.9% | +6.1% | +8.5% | +3.0% | +5.3% | -6.8% | +13.1% | +3.9% | +27.7% | +62.3% | +20.9% | +38.9% | +1.7% | -13.8% | -20.3% | -48.2% | -28.5% | -14.3% | -0.5% | |
| ROIC | 15.0% | 4.7% | 4.2% | 4.5% | 4.0% | 3.8% | 3.0% | 3.9% | 3.5% | 3.7% | 3.2% | 3.4% | 4.0% | 3.9% | 3.1% | 2.9% | 2.9% | 2.7% | 2.8% | 3.2% | 3.4% |
| — | +22.7% | +42.3% | +12.8% | +14.4% | +3.1% | -8.1% | +15.0% | -13.1% | -5.7% | +3.5% | +20.2% | +37.4% | +43.1% | +11.4% | -11.4% | -15.0% | -35.1% | -24.1% | -16.7% | +23.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | — | — | 0.02 | — | — | — | 0.01 | — | — | — | — | — | — | — | — | — | — | — | 0.01 | — |
| — | — | — | +91.1% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | 0.08 | — | — | 0.28 | — | — | — | 0.17 | — | — | — | — | — | — | — | — | — | — | — | 0.16 | — |
| — | — | — | +64.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 4.87 | 4.96 | 6.03 | 4.87 | 4.73 | 5.17 | 4.98 | 4.07 | 4.30 | 5.15 | 5.55 | 4.76 | 5.31 | 5.22 | 5.26 | 4.40 | 5.10 | 5.36 | 5.22 | 5.08 | 5.58 |
| — | -4.0% | +21.1% | +19.6% | +9.9% | +0.4% | -10.3% | -14.3% | -19.0% | -1.4% | +5.5% | +8.2% | +4.1% | -2.5% | +0.8% | -13.5% | -8.5% | -10.6% | -22.2% | -25.9% | -20.8% | |
| Quick Ratio | 3.96 | 3.91 | 5.01 | 3.96 | 3.74 | 4.18 | 3.97 | 3.22 | 3.42 | 4.22 | 4.61 | 4.02 | 4.63 | 4.57 | 4.54 | 3.77 | 4.42 | 4.74 | 4.63 | 4.57 | 5.01 |
| — | -6.6% | +26.2% | +22.8% | +9.4% | -0.8% | -13.8% | -19.8% | -26.1% | -7.7% | +1.5% | +6.7% | +4.6% | -3.6% | -2.0% | -17.6% | -11.6% | -12.6% | -23.7% | -26.7% | -20.5% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ISRG stock.
Intuitive Surgical, Inc.'s current P/E is 50.6x. The average P/E over the last 4 quarters is 53.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Intuitive Surgical, Inc.'s current operating margin is 29.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Intuitive Surgical, Inc.'s business trajectory between earnings reports.